(Q54345887)

28 May 2018

title

Intravitreal sustained-release cyclosporine in the treatment of experimental uveitis. (English)

1 reference

28 May 2018

1 reference

1 reference

G J Jaffe

1

1 reference

28 May 2018

C S Yang

2

1 reference

28 May 2018

X C Wang

3

1 reference

28 May 2018

S W Cousins

4

1 reference

28 May 2018

R P Gallemore

5

1 reference

28 May 2018

P Ashton

6

1 reference

28 May 2018

publication date

1 January 1998

1 reference

28 May 2018

published in

Ophthalmology

1 reference

28 May 2018

volume

105

1 reference

28 May 2018

issue

1

1 reference

28 May 2018

page(s)

46-56

1 reference

28 May 2018

Ocular penetration of cyclosporin A. III: The human eye

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2991176-9

7 January 2021

Renal function and blood pressure in patients receiving long-term, low-dose cyclosporine therapy for idiopathic autoimmune uveitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2991176-9

7 January 2021

Local cyclosporine therapy for experimental autoimmune uveitis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2991176-9

7 January 2021

Evaluation of a delivery system providing long-term release of cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2991176-9

7 January 2021

An intravitreal device providing sustained release of cyclosporine and dexamethasone

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2991176-9

7 January 2021

Clinical use of cyclosporine in ocular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2991176-9

7 January 2021

Effects of FK506, 15-deoxyspergualin, and cyclosporine on experimental autoimmune uveoretinitis in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2991176-9

7 January 2021

A masked, randomized, dose-response study between cyclosporine A and G in the treatment of sight-threatening uveitis of noninfectious origin

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2991176-9

7 January 2021

Low-dose cyclosporin A therapy in treating chronic, noninfectious uveitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2991176-9

7 January 2021

Antigen-independent activation of naive and memory resting T cells by a cytokine combination

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2991176-9

7 January 2021

Antigen-specific stimulation and trans-stimulation of T cells in long-term culture

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2991176-9

7 January 2021

Sustained release intravitreal dexamethasone

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2991176-9

7 January 2021

10.1016/S0161-6420(98)91176-9

Identifiers

DOI

1 reference

28 May 2018

1 reference

28 May 2018